EQUIMED 250 (Boldenone Undecylenate)

Overview

EQUIMED 250 (Boldenone Undecylenate) has both androgenic and anabolic properties (AAS), but is majorly used due to its potent anabolic activity. It is used to stimulate protein synthesis and appetite and also has an effect on erythropoietin for the treatment of anemias. EQUIMED 250 comes as boldenone undecylenate 250mg/ml injection, which contains boldenone undecylenate 250mg and excipients. 

Boldenone Undecylenate Mechanism of Action

Boldenone undecylenate is a prodrug (inactive form) which is eventually converted into its active form boldenone. It acts on the androgen receptor to elicit its anabolic effects. It also stimulates the kidneys to produce erythropoietin which stimulates the bone marrow to produce more red blood cells. It does not have progestogenic effects. It has a half-life of 14 days when given as an injection via the intramuscular route.

Boldenone Undecylenate Dosage

100mg - 200mg weekly given as intramuscular injection.

Boldenone Undecylenate Side Effects

Side effects include acne, virilization, gynecomastia, fluid retention, and scalp hair loss.

Boldenone Undecylenate Interactions

Boldenone Undecylenate interacts with estrogen grape seed extract.